loader image
CURE Pharmaceutical Completes $20 Million Acq…

– Acquisition to Support Cash Flow Positive Goal in ~18 Months – CURE Pharmaceutical Holdings (OTC: CURR) today announced its definitive agreement to acquire Sera Labs, Inc. The closing is anticipated to occur in early October. As previously announced, the…

CURE Pharmaceutical to Present at Two Virtual…

– CURE will present at the LD 500 Virtual Conference, September 4 at 8:20 am PDT –  – CURE CEO will be a panelist at the 4@4 Forum on September 10 @4pm PDT – OXNARD, Calif., Sept. 02, 2020 (GLOBE…

LD Micro:- 360 Companies– Set to Present thi…

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Source link

MicroCap Review Magazine Summer 2020 Issue No…

The Digital Issue of the Summer 2020 MicroCap Review Magazine, The Official Magazine for the MicroCap Stock Market, can be read on www.StockNewsNow.com LOS ANGELES, CA / ACCESSWIRE / August 11, 2020 / SNN Incorporated, a global multimedia financial news…

Sera Labs, a Leader in the CBD Industry with …

MOU to acquire 100% of privately held Sera Labs for $20 million, which consists primarily of stock with key earn out considerations totaling up to an additional $20 million within two years of completing the acquisition. Sera Labs brings to…

CURE Pharmaceutical to Acquire Sera Labs, a L…

CURE Pharmaceutical to Acquire Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, in a $20 Million Transaction U.S. markets close in 1 hour 53 minutes S&P 500 3,241.33 +1.92 (+0.06%)   Dow 30…

CURE Pharmaceutical CBD Oral Thin Film Pharma…

Significantly higher serum concentration and absorption Showcases CUREform™ encapsulation and oral thin film technology OXNARD, Calif., July 15, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that its 25mg cannabidiol (CBD)…

CURE Pharmaceutical Receives NSF’s cGMP Certi…

OXNARD, Calif., July 08, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical, (CURR), an innovative drug delivery and development company, today announced that its 25,000 square foot manufacturing facility has earned NSF International, cGMP certification for the manufacture of dietary supplements. This…

CURE Pharmaceutical Appoints Chief Business O…

– Jonathan Berlent Appointed to Newly Created Role – OXNARD, Calif., June 16, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical, (CURR), an innovative drug delivery and development company, today named Jonathan Berlent, 51, to the newly created position of Chief Business…

CURE Pharmaceutical Announces Exercise of War…

OXNARD, Calif., June 09, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical Holding Corp. (CURR), an innovative drug delivery company that is developing novel ways to deliver active ingredients, announced today that it strengthened its balance sheet with the receipt of $1.4…